HIV infection
Not recruitingStudy Comparing Two Drug Regimens for HIV: Lamivudine and Dolutegravir Sodium vs. Emtricitabine, Tenofovir Alafenamide, and Bictegravir in HIV-Positive Patients
Study Comparing Two Drug Regimens for HIV: Lamivudine and Dolutegravir Sodium vs. Emtricitabine, Tenofovir Alafenamide, and Bictegravir in HIV-Positive Patients
- Disease:HIV infection
- Substances:BictegravirDolutegravir Sodium+3
Belgium- Participants:18–64 years · 65+ years
- Substances:Bictegravir
- Sponsor:Universitair Ziekenhuis Gent











